Mark John Gilbert
CIK: 0001897698
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INDP
Indaptus Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Gilbert Mark John
Gilbert Mark John (SEC CIK 0001897698) files insider reports with the SEC as Director of Indaptus Therapeutics, Inc. (INDP).
Signal8 holds 1 ownership filing by Gilbert Mark John, a Form 4, filed on Jun 11, 2025. Those filings report 1 transaction, the latest on Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Gilbert Mark John's filings is in NEW YORK, NY.
Recent filings by Gilbert Mark John
- Jun 10, 2025: Grant or award of INDP derivative securities (Form 4, code A).
Other insiders filing for Indaptus Therapeutics, Inc. (INDP)
- Lu Qinglai, Director
- Yao Yun, 10% Owner
- SINO LION VENTURES Ltd, 10% Owner
- Dai Junyi, Chief Executive Officer
- Lazar David E., Director
- Jabbour Jerome D, Director